
Microsoft Backs Anthropic in Legal Fight Against Pentagon's AI Blacklist
Mar 11, 2026 01:04 am UTC| Business Technology Governance Law
Microsoft has stepped into a high-profile legal battle between AI startup Anthropic and the U.S. Department of Defense, filing an amicus brief in federal court in San Francisco to support Anthropics request for a temporary...

U.S. Senate Greenlights AI Chatbots for Official Staff Use
Mar 11, 2026 00:42 am UTC| Technology Business Politics Governance
The United States Senate has officially approved three major artificial intelligence chatbots for use by congressional staff, marking a significant step in the adoption of AI technology within the federal government....

FAA Issues Ground Stop for JetBlue Airways Flights Across All Destinations
Mar 10, 2026 05:45 am UTC| Governance Business
The U.S. Federal Aviation Administration (FAA) announced on Tuesday that a ground stop had been implemented for JetBlue Airways, affecting all of the carriers destinations nationwide. The temporary flight restriction was...

Venezuela Opens Mining Sector to Foreign Investment Under New Law
Mar 10, 2026 05:28 am UTC| Governance Economy Politics
Venezuelas ruling National Assembly has passed an initial vote on a landmark mining law designed to attract private and foreign investment into the countrys vast mineral sector. The legislation, backed by Acting President...

Trump Plans New Executive Order to Address Rising NIL Costs in College Sports
Mar 07, 2026 05:20 am UTC| Politics Governance Sports
U.S. President Donald Trump said Friday that the rapidly increasing costs associated with college football programs are harming collegiate athletics overall and pledged to introduce a new executive order within the next...

Mar 07, 2026 05:10 am UTC| Politics Governance Law
Federal immigration agents arrested a Colombian journalist working for a Spanish-language news outlet in Tennessee, drawing attention to immigration enforcement practices under President Donald Trumps administration....

FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
Mar 07, 2026 05:05 am UTC| Health Governance Business
Dr. Vinay Prasad, the controversial director of the U.S. Food and Drug Administrations Center for Biologics Evaluation and Research (CBER), will step down from his role at the end of April, according to FDA Commissioner...
India’s Investment Upgrade: A Historic Milestone for the "High-Quality EM" Narrative